Germline BRCA2 mutation in a patient with fallopian tube carcinoma: A casereport

Citation
Pg. Rose et al., Germline BRCA2 mutation in a patient with fallopian tube carcinoma: A casereport, GYNECOL ONC, 77(2), 2000, pp. 319-320
Citations number
12
Categorie Soggetti
Reproductive Medicine
Journal title
GYNECOLOGIC ONCOLOGY
ISSN journal
00908258 → ACNP
Volume
77
Issue
2
Year of publication
2000
Pages
319 - 320
Database
ISI
SICI code
0090-8258(200005)77:2<319:GBMIAP>2.0.ZU;2-V
Abstract
Objectives. Fallopian tube carcinoma is similar to ovarian and peritoneal c arcinoma with respect to histology, response to chemotherapy, and prognosis . BRCA germline mutations have been commonly reported in ovarian and perito neal carcinoma but rarely in other gynecologic cancers. Methods. A patient with fallopian tube carcinoma and a family history of ov arian carcinoma underwent genetic counseling and BRCA testing as did her da ughter. Results. The patient and her daughter were found to have a germline BRCA2 m utation. Conclusion. Like a family history of ovarian or peritoneal carcinoma, the o ccurrence of fallopian tube cancer should alert the clinician to the possib ility of an abnormality in the breast cancer susceptibility 1 or 2 genes. ( C) 2000 Academic Press.